MANCHESTER — Inside one of the new labs at the University of New Hampshire’s Manchester campus on a recent afternoon, assistant professor of biotechnology Kristen Johnson and two students evaluated genes as part of pancreatic cancer research.
The process is known as quantitative polymerase chain reaction, or qPCR.
“We are looking at various aspects of pancreatic cancer,” Johnson said. “We are trying to evaluate some of the things related to the DNA inside the cells.”
